Tags

Type your tag names separated by a space and hit enter

Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis.
Am J Ther. 2007 Sep-Oct; 14(5):442-6.AJ

Abstract

This clinical study was conducted to determine the efficacy and safety of Reliéva cream in adult patients with atopic dermatitis (eczema). This was an open-label trial in 42 patients with atopic dermatitis treated for 12 weeks with Reliéva cream (a homeopathic product containing Psorberine, a proprietary Mahonia aquifolium extract). Efficacy and safety was assessed using Eczema Area and Severity Index scores and a Subject Reported Evaluation of Treatment. The results showed significant (P < 0.05) improvements with respect to Eczema Area and Severity Index scores by comparison to subjects' baseline scores. In addition, subjects responding to a posttreatment evaluation questionnaire indicated a substantial benefit when rating effectiveness, itching, and appearance as a result of using the study preparation. Reliéva cream appears to be a safe and effective treatment for adult patients with atopic dermatitis (eczema).

Authors+Show Affiliations

Dermatology and Cosmetic Center of Rochester, Rochester, NY, USA.No affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17890932

Citation

Donsky, Howard, and Don Clarke. "Reliéva, a Mahonia Aquifolium Extract for the Treatment of Adult Patients With Atopic Dermatitis." American Journal of Therapeutics, vol. 14, no. 5, 2007, pp. 442-6.
Donsky H, Clarke D. Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis. Am J Ther. 2007;14(5):442-6.
Donsky, H., & Clarke, D. (2007). Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis. American Journal of Therapeutics, 14(5), 442-6.
Donsky H, Clarke D. Reliéva, a Mahonia Aquifolium Extract for the Treatment of Adult Patients With Atopic Dermatitis. Am J Ther. 2007;14(5):442-6. PubMed PMID: 17890932.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Reliéva, a Mahonia aquifolium extract for the treatment of adult patients with atopic dermatitis. AU - Donsky,Howard, AU - Clarke,Don, PY - 2007/9/25/pubmed PY - 2007/12/29/medline PY - 2007/9/25/entrez SP - 442 EP - 6 JF - American journal of therapeutics JO - Am J Ther VL - 14 IS - 5 N2 - This clinical study was conducted to determine the efficacy and safety of Reliéva cream in adult patients with atopic dermatitis (eczema). This was an open-label trial in 42 patients with atopic dermatitis treated for 12 weeks with Reliéva cream (a homeopathic product containing Psorberine, a proprietary Mahonia aquifolium extract). Efficacy and safety was assessed using Eczema Area and Severity Index scores and a Subject Reported Evaluation of Treatment. The results showed significant (P < 0.05) improvements with respect to Eczema Area and Severity Index scores by comparison to subjects' baseline scores. In addition, subjects responding to a posttreatment evaluation questionnaire indicated a substantial benefit when rating effectiveness, itching, and appearance as a result of using the study preparation. Reliéva cream appears to be a safe and effective treatment for adult patients with atopic dermatitis (eczema). SN - 1075-2765 UR - https://www.unboundmedicine.com/medline/citation/17890932/Reliéva_a_Mahonia_aquifolium_extract_for_the_treatment_of_adult_patients_with_atopic_dermatitis_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=linkout&amp;SEARCH=17890932.ui DB - PRIME DP - Unbound Medicine ER -